Where does Amorphyx, Incorporated rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Amorphyx, Incorporated ranks #22,175 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Amorphyx, Incorporated hold?

Amorphyx, Incorporated holds 12 US utility patents granted between 2019 and 2025, spanning 7 technology areas.

What is Amorphyx, Incorporated's Innovation Score?

Amorphyx, Incorporated has an Innovation Score of 33.8 out of 100 (45th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Amorphyx, Incorporated focus on?

Amorphyx, Incorporated's top technology area is H10D (Inorganic Electric Semiconductor Devices) with 9 patents, ranking #440 of 1,402 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Amorphyx, Incorporated's patent grant rate increasing or decreasing?

Amorphyx, Incorporated's recent grant velocity is +900% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Amorphyx, Incorporated's patents?

Amorphyx, Incorporated's patents average 19.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Amorphyx, Incorporated patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Amorphyx, Incorporated

USPTO PatentsView assignee record - 12 granted patents across 7 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H10D (Inorganic Electric Semiconductor Devices).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Amorphyx ranks #22,175 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 7 technology areas.

#22,175
of 49,997 US assignees by volume: 45th percentile
by Innovation Score (33.8/100): 19.6
avg claims per patent: +900%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R22175 · US Corporation #22,175 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #22,175/49,997
PHOTO-FINISH Altimmune
CPC-NARROW H10D · 7 areas
INNOV-THIN 33.8/100
CLAIMS-RICH 19.6 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +900% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Altimmune Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Amorphyx’s 33.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (26%) Velocity 3.8 pts (11%) Breadth 9.4 pts (28%) Claim depth 11.7 pts (35%)

Qualcomm Incorporated · highest

85
Shazam Investments · near

34
Woodward L'Orange · near

34
Amorphyx Incorporated · this assignee

34
Arcadia Biosciences · near

34
HMicro · near

34
3D Lighting… · lowest

7

What this shows Amorphyx's Innovation Score is 33.8/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Amorphyx?

Each dot is one of Amorphyx’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Amorphyx’s own 19.6 claims/patent is ABOVE the 15.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Amorphyx vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Amorphyx's grants concentrate

Amorphyx, Incorporated is a focused PatentsView assignee: 7 CPC subclasses with 75% of grants classified under H10D (Inorganic Electric Semiconductor Devices). Peak complete grant year is 2021 (4 grants) versus a trough of 1 in 2019. By volume, Amorphyx sits between Altimmune Inc. and Andritz Technology and Asset Management GmbH.

Amorphyx's three-year grant acceleration

Amorphyx, Incorporated shows 4 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Altimmune

12
Amann Girrbach

12
Amastan

12
Amneal Complex Pr…

12
Ample

12
Analogix Semicond…

12
And B

12
Andritz Technolog…

12
Amorphyx Incorpor… ◀

12

What this shows Amorphyx holds 12 patents at rank #22,209, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Amorphyx

By rank, the assignees closest to #22,209 in granted patent volume.

Leaders in H10D (Inorganic Electric Semiconductor Devices)

Other assignees with the most granted patents in Amorphyx's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Amorphyx, neither rank-band nor same-CPC leaders (those blocks stay above). In H10D (Inorganic Electric Semiconductor Devices), Amorphyx ranks #440 of 1,402 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

HMicro, Inc. 34 Arcadia Biosciences, Inc. 34 Shazam Investments Ltd. 34 Woodward L'Orange GmbH 34

Amorphyx's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 45th percentile higher than 45% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Amorphyx, Incorporated patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	8.3%
2020	2	16.7%
2021	4	33.3%
2023	2	16.7%
2024	2	16.7%
2025partial year	1	8.3%

Which technologies does Amorphyx, Incorporated patent most?

H10D - Inorganic Electric Semiconductor Devices 9

H01L - Semiconductor Devices NOT Covered BY Class H10 6

G02F - Optical Devices OR Arrangements FOR THE Control OF Light BY Modification OF THE Optical Properties OF THE Media OF THE Elements Involved THEREIN; Non-linear OPTICS; Frequency-changing OF LIGHT; Optical Logic ELEMENTS; Optical ANALOGUE/DIGITAL Converters 6

H10N - Electric Solid-state Devices NOT Otherwise Provided FOR 4

G09G - Arrangements OR Circuits FOR Control OF Indicating Devices Using Static Means TO Present Variable Information 3

H10F - Inorganic Semiconductor Devices Sensitive TO Infrared Radiation, Light, Electromagnetic Radiation OF Shorter Wavelength OR Corpuscular Radiation 2

H10K - Organic Electric Solid-state Devices 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Amorphyx, Incorporated's patent record in context - here's where to go next.

Amorphyx, Incorporated's lead technology class is H10D (Inorganic Electric Semiconductor Devices), 75% of its portfolio - see every assignee active in that class. Explore H10D
Ranked #22,175 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Amorphyx, Incorporated against Altimmune Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.